Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Absolutely. Although anyone who has been around this stock for awhile knew the play days ago. I smell desperation creeping on the short side. Nothing has changed.
This post should be sticky noted above.
Theswordman could you provide more context on this? Sounds very interesting.
Roll call. Still here. Still adding.
If they put up 6.5 million in cash they would not need a bond. This is what is confusing a lot of people the bond is there to offset putting the actual cash. Depending on credit worthiness and assets will tell the surety how much they will require the company to collateralize. The fact that they purchased a bond from Argonaut means they were underwritten and approved. All this nonsense of BK going around completely defies and underwritten surety just issued for 6.5 million. I don’t care how it is spun it is good news.
Ummmm… you do know this is a surety contingent upon credit and assets correct? Different underwriting criteria.
It’s not just that, if some understood the basics of how surety’s are underwritten they would know that this is good news. Now,… the real good news would be if we actually knew the terms of the collateral and if there was any collateral required at all…. Either way a surety would have declined the risk if the credit came back adverse. Period. This debunks a lot of what is being spread about the company by “FUDsters”
Argonaut is a legit surety. The fact that a surety was secured is a great sign. It means financials were evaluated and the decision was made by the insurance co to issue the bond. If Cytodyn had been required to post by an escrow or cash with no surety it would have been a different story. Sorry just facts but if true this is a good sign debunking much of the FUD being spread about the Co.
Wow…
Hmm.., I’m going to go with someone is gladly willing pay that 20% borrow fee because it’s cheaper than a LL approval.
Good to see you back Daemon! We’re all still here fighting!
Amarex would be wise to settle this sooner than later. Nobody wants their books audited for potential shortcomings and further potential uncovering of damages.
That cost is significantly reduced by showing cash on hand. For example they may choose to show 3.25 million of cash on hand and purchase a surety bond of 3.25 million for 1-2% or even less because they are showing the collateral. I estimated 5-50k total cost of bond depending on how they skin the cat. Or they pay zero and show 6.5 mill collateral on hand. This is a nothing burger as I’ve said before.
Not concerned with Nader. Just giving pure facts on what I know. Sorry if it doesn’t fit a narrative but it’s just facts. Maybe the bond issuing company gives a 50% requirement, maybe 20%, maybe nothing. Or maybe the bonding company says no thank you and Cytodyn places 6.5 million in a separate account until the case is settled or litigated and decided on. Either way let’s be honest with people here. Thanks and goodnight.
Nobody enjoys being forced to purchased an insurance policy but it’s really not worth splitting hairs on an investor board. It’s peanuts and a nothing burger. Several thousand dollars in insurance premiums won’t advance the counter argument. Sorry.
They could put 6.5 million in cash in an account or purchase a bond with less collateral. They aren’t giving anyone 6.5 million right now. Please see my prior posts.
The courts don’t care about opinions and feelings and patronizing. If Amarex caused damages they will pay.
Nah. You’re wrong. High litigation costs. Not surprised.
Haha! Now that’s a good one. I often speak of the parent child rule in my training sessions. I deal a ton of insurance related issues in MD. The parent child rule seems strong here. I will however say that those that are expecting some crazy windfall from this should not get their hopes up. However the last thing Amarex wants is an audit that could open Pandora’s Box.. think about that for a hot second.
It’s getting to that point. At 6.5 mill surety I would estimate the gap is narrowed on a settlement.., unless NSF is pulled in and no motion to relieve NSF is granted. Not sure if a motion by NSF was ever filed to have them not be a part of this… IMO.
NSF is trying to use separation of entities to avoid liability. Sidley’s goal is to pull them in. MD is contributory so they certainly are in the spotlight. The pressure is now on for them to settle. IMO
I’m not an attorney but I’ve read a lot of lawsuits dealing with insurance. I’d suspect Amarex will settle before this gets too far.. IMO. I’d be happy to help the Nader secure the bond if he needs assistance as I’m licensed in Maryland.
They aren’t covered by corporate liability policies. It’s a somewhat simple process but separate from general liability. For example, the premium paid for this bond will depend on financials or cash on hand. Some can simply show cash on hand and not have to purchase a surety bond. Some can elect to purchase the bond to not have ties to that cash on hand. The amount of collateral when purchasing a bond can reduce the cost. Off the cuff I would estimate CYDY would likely pay anywhere from 5-$50,000 for this bond.
Let me try again. I write surety bonds so I can speak freely on this. CYDY has two options. Show the collateral and avoid purchasing a surety bond or they can purchase a surety for likely a few thousand dollars premium. The cost of the surety bond may also depend on how much they are willing to collateral. The bond requirement is a nothing burger here.
Using the word “fail” is misleading to investors ways. A trial only fails if it’s shut down with no information or future trial formulation to build upon. I realize the use of trigger words on investor boards for attention is also part of the playbook.
I watched the video and it makes no sense why they pulled it. Claiming a “logo” misuse.. It was simply testimonials from real patients and very credible doctors.
Spot on Chump. Anyone paying close attention should take advantage.
2nd part of BLA submitted! Right on track!
Your point?
24th is coming soon 3X. Hopefully you will get a breather.
Sure... And 10 months later Nader is still CEO and the board is still recommending him going forward. Narrative is over on that talking point lol.
I’m sure things will quiet down by the 24th on some of these boards…. Hang in there
Pretty simple. CYDY wants its data, and Amarex wants its money. Sidley is no slouch when it comes to negotiations. Walking away from negotiations tells me CYDY is not as desperate as some would like to have others believe. And let’s go a little further for those that spread FUD.. Cytodyn isn’t in perilous shape either. No company chases litigation and fighting the way they do if the writing is on the wall.. Dying on the vine companies do not choose to proactively put up money to get what they know will be successful across the finish line.
Great news today officially getting BTD filed. These are the types of things that we need to see from this amazing drug. Let’s save lives!
This is massively oversold regardless of all the “emotional” nonsense.
You are 100% correct my friend. I’m watching. I’d also add the massively oversold conditions as a binary event itself.
At this point their intention is purely to remove Nader. They know they have lost but this is the final move to accomplish something in their view. I will say imo that the SP has been met with the battle hardened longs at this point. The cake is baked.
Those shares were never intended for immediate dilution. I see how easy it is to spin that narrative though…
It would be up to the board to seek a qualified CEO. Change is not always a bad thing if done properly and orderly. Today’s lack of quorum tells me shareholders either went 13D or didn’t vote. If a CEO is beloved quorum happens. It’s a distraction and it’s time for change.
I voted. And I voted a lot of shares.., IMO when a CEO right or wrong becomes the distraction they should step down. I voted for all other aspects with the exception of Nader and the comp package. The CEO must have the charisma and ability to bring people together regardless of bio experience. Many CEOs I deal with are not necessarily the expert in everything related but know exactly how to communicate extraordinarily well. This is purely a business decision. 13D is irrelevant IMO.